Ernesto Marcos López

Title: The Innovative Contributions of Ernesto Marcos López

Introduction

Ernesto Marcos López is a notable inventor based in La Habana, Cuba. He has made significant strides in the field of biotechnology, particularly in the development of vaccines. His work focuses on addressing critical health challenges, such as the dengue virus.

Latest Patents

López holds a patent for a dengue virus vaccine composition. This innovative vaccine comprises at least one antigen based on the dengue virus (DV) capsid protein and the oligonucleotide identified as SEQ ID NO 1. The composition includes a fusion protein formed by the DV2 capsid and domain III of the envelope protein of the same serotype. This formulation has been shown to elicit higher levels of cellular immune response and protection in mice compared to previous formulations. The efficacy of these compositions has also been demonstrated in non-human primates. The vaccine can be monovalent, bivalent, or tetravalent, and is designed to induce a functional immune response to the four viral serotypes.

Career Highlights

Throughout his career, Ernesto Marcos López has worked with prominent institutions such as the Centro de Ingeniería Genética y Biotecnología. His contributions to vaccine development have positioned him as a key figure in the fight against infectious diseases.

Collaborations

López has collaborated with various professionals in his field, including Lázaro Gil González. Their joint efforts have further advanced the research and development of effective vaccine solutions.

Conclusion

Ernesto Marcos López's innovative work in vaccine development showcases his commitment to improving public health. His contributions, particularly in the area of dengue virus vaccines, highlight the importance of research and innovation in combating infectious diseases.